-
Peter Lundh von Leithner
Ocular Biology and Therapeutics, University College London Institute of Ophthalmology, London, United Kingdom
-
Sabine Uhles
Pharma Research and Early Development, Ophthalmology Discovery and Biomarkers, Roche Innovation Center Basel, F Hoffmann - La Roche Ltd., Basel, Switzerland
-
Vivian Lee
Ocular Biology and Therapeutics, University College London Institute of Ophthalmology, London, United Kingdom
-
Christoph Ullmer
Pharma Research and Early Development, Ophthalmology Discovery and Biomarkers, Roche Innovation Center Basel, F Hoffmann - La Roche Ltd., Basel, Switzerland
-
Brett Hosking
Ocular Biology and Therapeutics, University College London Institute of Ophthalmology, London, United Kingdom
-
Juergen Fingerle
Pharma Research and Early Development, Ophthalmology Discovery and Biomarkers, Roche Innovation Center Basel, F Hoffmann - La Roche Ltd., Basel, Switzerland
-
David Shima
Ocular Biology and Therapeutics, University College London Institute of Ophthalmology, London, United Kingdom
Pharma Research and Early Development, Ophthalmology Discovery and Biomarkers, Roche Innovation Center Basel, F Hoffmann - La Roche Ltd., Basel, Switzerland
-
Susanne Raab
Pharma Research and Early Development, Ophthalmology Discovery and Biomarkers, Roche Innovation Center Basel, F Hoffmann - La Roche Ltd., Basel, Switzerland
-
Richard Foxton
Ocular Biology and Therapeutics, University College London Institute of Ophthalmology, London, United Kingdom